October 3, 2013 (CHAPEL HILL, NC) Thought Leader Select has accepted a new key opinion leader (KOL) strategy engagement with a global biopharmaceutical leader in the treatment area of diabetes. The client company, one of the world’s top five industry leaders in the development of medications for managing type I and type II diabetes, tabbed North …
Thought Leader Select Lands New KOL Strategy Engagement in Diabetes Read More »
Industry Insights from Paul Meade, M. Sc, MPH Everyone seems to have a definition of what a thought leader, or key opinion leader, or external expert is. These honorifics are routinely bestowed upon the most revered people in our society. Most industries—not just healthcare—have thought leaders, but not everyone views them in the same way. …
March 23, 2011 (CHAPEL HILL, NC)—Thought Leader Select, a research and consulting firm focused on healthcare and the biopharmaceutical industry, has initiated its most comprehensive package of research assessments in support of a new dermatology medication for a global pharmaceutical company. The Research Triangle, NC-based firm packaged together a host of its competitive services for …
New press release out today from the offices of Thought Leader Select: Thought Leader Select announces 50 Percent Annual Growth for 2010 FOR IMMEDIATE RELEASE February 3, 2010 (CHAPEL HILL, NC)-Thought Leader Select, a Research Triangle, NC-based research and consulting company serving the biopharmaceutical and healthcare industries, announces 50 percent year-over-year growth for 2010. Founded …
Thought Leader Select announces 50 Percent Annual Growth for 2010 Read More »
November 16, 2010 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina firm dedicated to delivering the most accurate and effective key opinion leader (KOL) profiling research for the biopharmaceutical industry, announces the launch of a drug reimbursement project for a top-10 US pharmaceutical company. With a new drug for treating coagulation coming to the market …
